                         SEQUENCE LISTING

<110>  NOVARTIS AG
 
<120>  GLUCAGON LIKE PEPTIDE COMPOUNDS

<130>  PAT059040-EP-EPA

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  1

His Ala Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Arg Gly 
            20                  25                  30      


<210>  2
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  misc_feature
<222>  (1)..(2)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  VaI or Leu

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Ser, Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Tyr or GIn

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Leu or Met

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  GIy, Glu or Aib

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  GIn, Glu, Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Ala or VaI

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Glu or Leu

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Ala, Glu or Arg

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  VaI or Lys

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Lys, Glu, Asn or Arg

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  GIy or Aib

<220>
<221>  MISC_FEATURE
<222>  (30)..(30)
<223>  Arg, GIy or Lys, or is absent

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  GIy, Ala, Glu, Pro, Lys, or is absent

<400>  2

Xaa Xaa Glu Gly Thr Phe Thr Ser Asp Xaa Ser Xaa Xaa Xaa Glu Xaa 
1               5                   10                  15      


Xaa Ala Xaa Arg Xaa Phe Ile Xaa Trp Leu Xaa Xaa Xaa Xaa Xaa 
            20                  25                  30      


<210>  3
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aib

<400>  3

His Xaa Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Arg Gly Arg Gly 
            20                  25                  30      


<210>  4
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  4

His Ala Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Arg Gly Arg Gly 
            20                  25                  30      


